Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a monoclonal antibody therapy for advanced kidney cancer (renal cell carcinoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer | Phase 2 | Status: COMPLETED